Trial Profile

Comparison of the effects of nebivolol versus metoprolol succinate on endothelial function and large artery stiffness

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nebivolol (Primary) ; Metoprolol succinate
Indications Essential hypertension
Focus Biomarker; Pharmacodynamics
Acronyms NEMENDAS
Sponsors Berlin Chemie; Menarini

Most Recent Events

01 Sep 2012 Results published in the Scandinavian Journal of Clinical and Laboratory Investigation.
02 May 2011 Results published in Hypertension.
24 Nov 2010 Additional lead trial investigator (Jaan Eha) and actual initiation date (Mar 2006) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com